Subscribe To
WW / WW International CEO on weight loss drugs: Still critical you make the right lifestyle changes
WW News
By The Motley Fool
October 27, 2023
Why WW International Stock Slipped This Week
WW International is the parent company of Weight Watchers. The company has seen declining sales for the last five years. more_horizontal
By Seeking Alpha
October 25, 2023
WW International: Dying Core Business Overshadows Risky Pivot
WW International's core Weight Watchers business is struggling with falling revenues and subscribers in a competitive market. The company's acquisitio more_horizontal
By GlobeNewsWire
October 19, 2023
WW International, Inc. Schedules Third Quarter 2023 Earnings Conference Call
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release it more_horizontal
By The Motley Fool
October 12, 2023
Why WW International Stock Was Bulking Up This Week
The most famous individual associated with the weight-loss specialist made some remarks that were taken positively. She walked back previous utterance more_horizontal
By The Motley Fool
October 9, 2023
Why WW International Stock Was Jumping Today
Oprah Winfrey gave her support to using drugs like Ozempic for weight loss. Winfrey also purchased some Weight Watchers stock last week. more_horizontal
By GlobeNewsWire
September 8, 2023
WW International, Inc. Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announce more_horizontal
By Seeking Alpha
August 16, 2023
WW International's Ozempic Gamble
Weight Watchers, now known as WW International, has transitioned from a weight loss program to a health and wellness technology company. The company's more_horizontal
By CNBC Television
August 16, 2023
This is the first time in WW history that Q2 ended higher than Q1, says CEO Sima Sistani
Sima Sistani, WW International CEO, joins 'Closing Bell Overtime' to talk weight loss drugs, growth in WW's digital platforms and the stock's reaction more_horizontal